Casdin Capital, LLC 13D and 13G filings for Relay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:47 pm Unchanged | 2025-12-31 | 13G | RELAY THERAPEUTICS INC RLAY | Casdin Capital, LLC | 13,003,574 7.500% | 0 (Unchanged) | Filing |
| 2026-02-17 4:45 pm Purchase | 2025-12-31 | 13G | RELAY THERAPEUTICS INC RLAY | Casdin Capital, LLC | 13,003,574 7.500% | 5,615,631 (+76.01%) | Filing |
| 2024-02-14 4:20 pm Purchase | 2023-12-31 | 13G | RELAY THERAPEUTICS INC RLAY | Casdin Capital, LLC | 7,387,943 5.990% | 1,089,369 (+17.30%) | Filing |
| 2023-10-02 4:14 pm Purchase | 2023-09-21 | 13G | RELAY THERAPEUTICS INC RLAY | Casdin Capital, LLC | 6,298,574 5.160% | 6,298,574 (New Position) | Filing |